HealthcareServices

Self-Administered Parenteral Market Anticipated to Record Steady Gains, Advancing to $32.19 Billion by 2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the self-administered parenteral market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Self-Administered Parenteral Market?

The self-administered parenteral market has shown consistent expansion in recent years. Projections indicate it will grow from $25.84 billion in 2025 to $27.01 billion in 2026, with a compound annual growth rate (CAGR) of 4.5%. This market’s historical growth can be attributed to factors such as increasing chronic disease prevalence, the adoption of home-based treatments, advances in prefilled syringes, rising awareness of self-injection therapy, and the growth of biopharma.

The self-administered parenteral market size is anticipated to experience consistent growth in the upcoming years. It is projected to expand to $32.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.5%. This expansion over the forecast period is driven by the development of smart injector technologies, the integration with mobile health applications, customized dosage solutions, the broadening of autoimmune and oncology therapy, and regulatory encouragement for self-administration. Key developments during this period will encompass smart auto-injectors, increased adoption of prefilled syringes, on-demand therapy delivery, devices connected to telemedicine, and personalized drug dosage solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

What Drivers Are Supporting Technological Adoption In The Self-Administered Parenteral Market?

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the self-administered parenteral market in the future. Chronic diseases are enduring medical conditions that typically progress gradually and necessitate ongoing management and treatment. Self-administered parenteral products facilitate independent treatment management for chronic diseases, which can significantly enhance patient adherence compared to oral medication. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This figure is expected to more than double, reaching 1.3 billion individuals by 2050. Therefore, the escalating incidence of chronic diseases is a primary driver for the growth of the self-administered parenteral market.

Which Segments Are Contributing To The Growth Of The Self-Administered Parenteral Market?

The self-administered parenteral market covered in this report is segmented –

1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products

2) By Usage: Disposable, Reusable

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels

4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Subsegments:

1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes

2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors

3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors

4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices

Which Market Trends Are Opening Growth Opportunities In The Self-Administered Parenteral Market?

Leading companies in the self-administered parenteral market are concentrating on developing innovative products, such as the UDENYCA autoinjector, to offer increased choice and control, thereby enhancing treatment accessibility for patients. An autoinjector is a medical device engineered to deliver a single dose of a specific drug, featuring an intuitive design where administration is triggered immediately and reliably by push-on-skin activation. For instance, in May 2023, Coherus BioSciences Inc., a US-based biotech company, introduced the UDENYCA autoinjector, a self-administered parenteral medication, in the US. The UDENYCA Autoinjector is a single-dose, prefilled autoinjector that provides patients with an additional administration option for pegfilgrastim. Its design is intuitive, with delivery initiated by push-on-skin activation, ensuring reliable and immediate dispensing of a full pegfilgrastim dose. Additionally, it includes several user-friendly features that facilitate successful delivery, such as fast dosing, intuitive design, dual coverage, suitability for at-home and in-office use, and a reduction in the risk of febrile neutropenia.

Who Are The Prominent Global Companies Shaping The Self-Administered Parenteral Market Landscape?

Major companies operating in the self-administered parenteral market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A S, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N V, Terumo Corporation, Catalent Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, ScPharmaceuticals Inc., Fresenius Kabi AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Self-Administered Parenteral Market?

North America was the largest region in the self-administered parenteral market in 2025. The regions covered in the self-administered parenteral market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Self-Administered Parenteral Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp

Browse Through More Reports Similar to the Global Self-Administered Parenteral Market 2026, By The Business Research Company

Large Volume Parenteral Lvp Market Report 2026

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Parenteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

Small Volume Parenteral Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795